China

WuXi AppTec prices Hong Kong offering in stormy market
WuXi AppTec prices Hong Kong offering in stormy market
BioCentury
China
Hong Kong
WuXi AppTec
Flag link:
China approves Descovy, Harvoni, Hemlibra
China approves Descovy, Harvoni, Hemlibra
BioCentury
China
Harvoni
Descovy
Hemlibra
Roche
Gilead Sciences
Flag link:
Pfizer strikes deal with Chinese online pharmacy Jianke
Pfizer strikes deal with Chinese online pharmacy Jianke
Pharmaforum
Pfizer
China
Jianke
Flag link:
Chi-Med, Innovent enter global cancer partnership
Chi-Med, Innovent enter global cancer partnership
BioCentury
Chi Med
Innovent Biologics
China
solid tumors
Flag link:
30 New Drugs from Foreign Countries Approved in China in Last 21 Months
30 New Drugs from Foreign Countries Approved in China in Last 21 Months
BioSpace
China
drug approvals
Flag link:
Chinese foothold in U.S. biotech is growing, USTR report finds
Chinese foothold in U.S. biotech is growing, USTR report finds
BioCentury
China
biotech
Flag link:
Roche ties up again with Ascletis — this time on a commercial partnership for hep B drug
Roche ties up again with Ascletis — this time on a commercial partnership for hep B drug
Endpoints
Roche
hepatitis B
China
Hong Kong
Ascletis
Pegasys
Flag link:
Alphamab raises more than $100M series A
Alphamab raises more than $100M series A
BioCentury
China
immuno-oncology
Alphamab Oncology
Flag link:
Eli Lilly Could Sell Some Older China Assets for up to $300 Million
Eli Lilly Could Sell Some Older China Assets for up to $300 Million
BioSpace
Eli Lilly
China
Flag link:
After historic win, Lilly partner Chi-Med’s Elunate flops in lung cancer
After historic win, Lilly partner Chi-Med’s Elunate flops in lung cancer
Fierce Pharma
China MediTech
Elunate
Eli Lilly
China
non-small cell lung cancer
Flag link:
Trump, Xi talks boost Chinese biopharma stocks
Trump, Xi talks boost Chinese biopharma stocks
BioCentury
China
Donald Trump
Xi Jinping
Flag link:
Eli Lilly partner urges investors to look beyond biotech turmoil
Eli Lilly partner urges investors to look beyond biotech turmoil
Indianpolis Business Journal
Innovent Biologics
Eli Lilly
China
biotech
Flag link:
Merck cuts back on vaccine commitment to West Africa as shipments to China ramp up
Merck cuts back on vaccine commitment to West Africa as shipments to China ramp up
Stat
Merck
vaccines
West Africa
China
rotavirus
Flag link:
Chinese Biotech Bio-Thera Solutions Initiates Ph III Trial of HER2 ADC in Metastatic Breast Cancer
Chinese Biotech Bio-Thera Solutions Initiates Ph III Trial of HER2 ADC in Metastatic Breast Cancer
CP Wire
Bio-Thera Solutions
HER2-positive metastatic breast cancer
BAT8001
China
Flag link:
3 Big Pharma Stocks Racing Along the Road to China
3 Big Pharma Stocks Racing Along the Road to China
Motley Fool
China
cancer
Pfizer
AstraZeneca
JNJ
Flag link:
Novartis signs manufacturing deal for Kymriah in China
Novartis signs manufacturing deal for Kymriah in China
BioCentury
Novartis
Kymriah
China
drug manufacturing
Flag link:
Chinese pharma market primed for growth after sweeping reforms
Chinese pharma market primed for growth after sweeping reforms
Pharmaforum
China
Flag link:
As China builds biotech sector, cash floods U.S. startups
As China builds biotech sector, cash floods U.S. startups
Yahoo/Reuters
China
biotech
startups
Flag link:
Allergan, eyeing Asia for growth, pours $14.7M into first medical aesthetics center in China
Allergan, eyeing Asia for growth, pours $14.7M into first medical aesthetics center in China
Fierce Pharma
China
Allergan
Flag link:
AZ expands role in China, to include robots and health tech
AZ expands role in China, to include robots and health tech
Pharmaforum
AstraZeneca
China
robotics
digital health
artificial intelligence
Flag link:

Pages